Risk-Based Inspection (RBI) is a GMP approach where regulators plan the frequency, depth and breadth of inspections according to the estimated risk to patients and product quality, using Quality Risk Management and risk signals from a site’s history. Schedule M…
Risk Based Inspection (RBI) – Schedule M Point 4.9 (Microbiological detection levels for EM limits) In RBI, inspectors focus more deeply on contamination control because failures can directly affect patient safety. Risk-based inspection planning typically varies the frequency, depth, and…
Risk-Based Inspection (RBI) rates a site by the risk it may pose to patients and product quality and then decides the frequency, depth and breadth of inspection accordingly, using Quality Risk Management. CDSCO In Schedule M (Sterile Products), points 4.5–4.8…
Risk-Based Inspection (RBI) lets regulators decide the frequency, depth and breadth of GMP inspections using Quality Risk Management, focusing more effort on systems that could impact patients, product quality, and users. CDSCO Schedule M – Point 4.4 (What it requires)…
In a risk-based inspection (RBI), Schedule M points 4.1–4.3 (in the CDSCO RBI checklist under Water & Compressed air system) are treated as critical utility controls, because an uncontrolled water system can cause microbial/chemical contamination, endotoxin risk, and batch impact…
In a risk-based inspection (RBI), Schedule M (Sterile Products) points 3.1–3.4 “Sanitation” are assessed as direct controls for sterility assurance and contamination control—because ineffective cleaning/disinfection can immediately impact Grade A/B/C/D areas and lead to environmental excursions or sterility failures. 3.1…
In Schedule M (Part I), Point 2.6 sits under “Warehousing Area” and requires that rejected, recalled, or returned materials/products are segregated in storage, with the area/items clearly marked, secured, and access restricted to authorized persons. Why Point 2.6 matters in…
In a risk-based inspection (RBI), Schedule M – Point 2.4 (Quarantine controls in warehouse/store) is assessed as a critical “quality gate” because quarantine is the main barrier preventing unreleased/untested materials or products from entering manufacturing or dispatch. What Point 2.4…
In a risk-based inspection (RBI), Schedule M – Point 2.4 (Warehousing area) is assessed as a high-severity mix-up and quality-gate control, because quarantine is the main barrier preventing unreleased/untested materials or products from entering manufacturing or dispatch. Regulatory intent (what…
In a risk-based inspection (RBI), Schedule M points 2.2 and 2.3 are assessed under warehousing and material movement controls, because weak storage/receiving practices can lead to temperature/humidity damage, contamination, mix-ups, and use of unreleased materials—all of which directly impact patient…